Propofol may cause histamine release and alter airway tone and reactivity. Although its use has been reported to be safe in asthmatics, there is a lack of information on its effect on lung function in children with asthma. We measured respiratory mechanics after i.v. or inhalation anaesthesia in 60 children, aged 2-12 yr, with or without asthma. Anaesthesia was induced with propofol 3 mg kg (ns)). Halothane produced a minimal decrease in Rrs and a minimal increase in tidal volume in both groups without changes in Crs,dyn. In conclusion, respiratory mechanics were comparable after propofol anaesthesia in both children with and without asthma. Changes in Rrs after halothane administration were not clinically relevant. (Br.
and 50% nitrous oxide in oxygen. Halothane was administered subsequently at a concentration of 1 MAC. Respiratory mechanics were measured by applying a single-compartment model using multi-linear regression analysis to calculate dynamic compliance (Crs,dyn) and respiratory system resistance (Rrs), based on: Pao : V/Crs,dyn ; V Rrs ; PA,EE, where Pao : airway opening pressure, PA,EE : alveolar pressure, V : volume and V : flow. The two groups were comparable in age, weight and ventilation variables (tidal volume and peak pressure). Respiratory mechanics during propofol anaesthesia were comparable in normal and asthmatic children (Rrs : (ns)). Halothane produced a minimal decrease in Rrs and a minimal increase in tidal volume in both groups without changes in Crs,dyn. In conclusion, respiratory mechanics were comparable after propofol anaesthesia in both children with and without asthma. Changes in Rrs after halothane administration were not clinically relevant. (Br. J. Anaesth. 1996; 77:
739-743)
With the worldwide increase in the prevalence of asthma [1] [2] [3] an increased number of asthmatics are likely to require anaesthesia for surgical procedures. As asthma is characterized by increased airway reactivity to different stimuli, the choice of anaesthetic technique should consider the increased risk of bronchospasm in children with asthma. Anaesthesia may induce changes in airway resistance, alter ventilation distribution, produce atelectasis and reduce lung volume, 4 any of which may result in hypoxaemia.
Propofol has several advantages for use in paediatric anaesthesia. It has been shown to reduce the incidence of airway obstruction at induction, 5 shorten recovery time and allow earlier discharge for outpatients, 6 7 and to reduce postoperative emesis. 8 9 However, propofol has been reported to induce histamine release in healthy 10 and atopic patients.
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Excessive histamine release may provoke bronchoconstriction in asthmatic patients and would limit its usefulness in this group. While propofol has been reported to be safe in asthmatic patients, [12] [13] [14] there is a lack of information on its effect on lung function in asthmatics, particularly children. Objective lung function data are required before recommending the use of propofol in asthmatic children.
This study was designed to measure respiratory mechanics in children with asthma undergoing mechanical ventilation during (i) induction of anaesthesia with propofol and (ii) maintenance of anaesthesia with halothane in children with and without asthma. For practical reasons respiratory mechanics were measured during propofol anaesthesia first, followed by measurements during halothane anaesthesia.
classified as having asthma (children with a history of physician diagnosed asthma, stabilized under medical treatment before undergoing surgery) or not (children with normal lungs and no history of asthma, hay fever or allergies). Children with a history of upper respiratory infection within 4 weeks, and children with acute or chronic respiratory disease other than asthma were excluded.
All children had EMLA cream applied on both hands 1 h before surgery, and received oral midazolam 0.25-0.35 mg kg
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, 30 min before induction of anaesthesia with propofol 3 mg kg 91 and fentanyl 1 g kg
. Propofol was then continued at a rate of 10 mg kg 91 h 91 in the presence of 50% nitrous oxide in oxygen while respiratory mechanics were measured. A tracheal tube was inserted after administration of atracurium 0.5 mg kg
. The size of the uncuffed tracheal tube was chosen to avoid leak at the pressures encountered during mechanical ventilation. If a leak was detected around the tracheal tube, a throat pack was inserted or cricoid pressure was applied, or both, during measurements. The lungs were ventilated mechanically with a volumecontrolled ventilator (Air-Shields Ventimeter Controller) and ventilatory frequency was titrated to achieve an end-tidal carbon dioxide concentration of approximately 4.6 kPa. After respiratory measurements were obtained during infusion of propofol, anaesthesia was subsequently maintained with 1% halothane and 50% nitrous oxide in oxygen.
The measurement equipment, consisting of a pressure port and transducer (Microswitch 142 PC01D) to measure airway opening pressure (Pao) and a pneumotach (Hans Rudolph Inc. K.C., MO, USA) to measure flow (V) was placed between the patient's tracheal tube and the ventilator circuit. Pao and V signals were amplified (Applied Measurement, 022A), low-pass filtered (cut-off frequency 10 Hz, Applied Measurement, 043) and stored on computer. All data were collected and analysed using a data acquisition package (Anadat and Labdat, RHT Infodat, Montreal, Canada).
MEASUREMENT OF RESPIRATORY MECHANICS
Respiratory mechanics were measured during mechanical ventilation using well characterized methods. 15 16 Multi-linear regression analysis was used to calculate respiratory system compliance (Crs,dyn) and resistance (Rrs) from measurements of airway opening pressure (Pao), flow (V) and volume (V) using the equation:
The constant term in equation (1) (PA,EE) reflects alveolar pressure. 17 Data were used only if the coefficient of determination (r 2 ) of this fit was 9 0.98.
CORRECTION FOR GAS PHYSICAL PROPERTIES
Measurements of flow obtained from a pneumotachograph are influenced by the physical properties of the gas passing through. When using gases with different physical properties, one must correct for this effect. We used the principles applied by Johns, Pretto and Streeton 18 to determine the appropriate correction factor for the gas concentrations used in this study. Using a 100-ml syringe filled with the gas mixture used in each part of the study, 100 ml of gas were flushed through the pneumotachograph and the resulting flow integrated to produce a volume measurement. By repeating this manoeuvre 20 times with each gas mixture, the relevant correction factors were calculated and subsequently applied to the flows measured with the relevant gas mixture.
STUDY DESIGN
All measurements were completed in the anaesthetic induction room before surgical stimulation. After tracheal intubation and 5 min of steady state mechanical ventilation during infusion of propofol, a first set of three discrete 20-s epoch measurements were obtained. Infusion of propofol was then discontinued and anaesthesia was maintained with 1% halothane and 50% nitrous oxide in oxygen. An anaesthetic gas analyser (ICOR agent ANM 605) was used to determine when a steady state concentration had been reached. An expiratory halothane concentration of 0.7% (1 MAC) was achieved within 5-8 min. Measurements of respiratory mechanics were then repeated.
STATISTICAL ANALYSIS
A 20% difference in resistance (Rrs) between asthmatic and normal children, or a 20% change in Rrs with anaesthetic were considered clinically significant. Based on the intra-subject variability of Rrs, calculated using the multi-linear regression technique, 15 19 groups of 30 subjects have been shown to have 95% power to detect a 20% difference in Rrs between groups.
Comparisons between asthmatic and normal children were made using the unpaired two-tailed t test. Paired two-tailed t tests were used to compare changes in respiratory mechanics before and after administration of halothane. Statistical significance was accepted at the 5% level. Data analysis was performed using SPSS 6.1 for Windows. Data are presented as mean (SD).
Results
The two groups of patients were comparable in age, weight, sex and size of the tracheal tube (table 1) . The different clinical patterns and treatment of asthma are shown in table 2. Seventeen of the asthmatic children had received a bronchodilator on the morning before admission to theatre. There was no significant difference in airway resistance between the asthmatic children who received bronchodilators ). Ventilation variables were comparable between the groups. With the ventilator set to achieve an end-tidal carbon dioxide concentration of approximately 4.6 kPa, the lungs of the children were ventilated with a tidal volume of approximately 10 ml kg 91 and a frequency of 0.25 Hz, with an inspiratory-expiratory time ratio of 0.5 (table 3) . There were no significant differences between the two groups in airway pressure (peak pressure, mean pressure and end-expiratory pressure) and respiratory mechanics (dynamic compliance and resistance) (table 4).
During administration of halothane, in both groups there was a significant increase in tidal volume and a decrease in Rrs, while Crs,dyn did not change (table 4) . Both of these changes were small and not clinically significant. Furthermore, changes in tidal volume and respiratory mechanics were equivalent in both groups before and after administration of halothane. The decrease in airway resistance was comparable in asthmatic patients who had received bronchodilators in the morning and those who had not (7. ).
Discussion
We have found that respiratory mechanics were comparable in asthmatic and non-asthmatic children after induction of anaesthesia with propofol. Furthermore, changes during halothane anaesthesia were not clinically significant suggesting that propofol was not associated with any adverse effects in children with or without asthma. This study provides information on respiratory mechanics in children with and without asthma, receiving routine induction of anaesthesia with propofol, followed by maintenance with halothane. This anaesthetic regimen mimics that which would be used clinically in children, if propofol was shown to be safe in children with asthma. Ideally, we would have wished to obtain measurements of respiratory mechanics before and after propofol and before and after halothane. This design is impractical as propofol is given to induce anaesthesia. If anaesthesia was induced with a volatile agent, such as halothane, the presence of this agent would be likely to mask any changes caused by propofol. In addition, the design used in this study mimics the clinical situation in which these drugs are used. To circumvent our inability to measure respiratory mechanics before and after introduction of propofol, we compared results obtained in asthmatic and nonasthmatic children and after achieving a concentration of 1 MAC of halothane. If propofol produced bronchospasm in children, we would have expected to see a significant decrease in Rrs after introduction of halothane. Similarly, if propofol had more adverse effects in asthmatic children, we would have expected to find a higher resistance in this group compared with the control, and a bronchodilator response with halothane. Neither of these patterns was seen. Some reports have suggested that propofol causes histamine release in healthy 10 and atopic patients, 11 and may induce bronchospasm. 20 21 To our knowledge, there are no reports of respiratory mechanics after propofol anaesthesia in children. In this study, Rrs was slightly higher in asthmatic children and this difference was found at all stages of the study but was not statistically significant. The difference in group means was small (: 1.0 10 94 kPa ml 91 s
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) and not clinically significant. Crs,dyn was also slightly lower in the asthmatic group. These differences may have resulted from either differences in baseline lung function or greater propofol-induced histamine release in asthmatic children. In both cases the differences were too small to be considered important and suggest that the use of propofol is safe in children with asthma.
It has also been suggested that propofol causes greater bronchospasm when combined with another histamine-releasing substance such as atracurium, 22 which can induce histamine-release from mast cells. 23 All children in this study received propofol and atracurium at induction of anaesthesia. If histamine release was a significant clinical problem with either or both of these drugs, we might have expected a greater effect in asthmatic children as airway sensitivity to histamine is increased in asthmatics. 24 However, we did not observe any significant differences in ventilation variables or in respiratory mechanics between the two groups of children. These findings support a recent study in which it was found that atracurium 0.5 mg kg 91 had no clinically significant effects on the airways. 25 Halothane produced small but consistent bronchodilatation in both groups and the decrease in Rrs was similar in children with and without asthma. Previous studies have shown that halothane reduces airway resistance, primarily when increased by chemical agonists. 26 27 Most recently, 1 MAC of halothane has been found to dilate the airways of normal canine lungs without preconstriction. 28 These authors also showed that halothane does not exert any effect on lung tissue mechanical properties. While one must always be cautious in extrapolating data from animal studies to humans, our results are consistent with these findings as our single compartment model was sensitive enough to detect a mild but statistically significant decrease in Rrs without any change in Crs,dyn. The decrease in Rrs contributed to the mild increase in tidal volume which was not clinically significant.
While no changes in group mean lung function occurred, to ensure that no clinically important subgroup was missed, we examined the magnitude of the reductions in resistance occurring in individual children. A 10% decrease in resistance is the minimum that would be considered clinically significant and is well beyond the variability of our measurements. One non-asthmatic and four asthmatic children showed a reduction in resistance of 10% or more after introduction of halothane and no child had a change of 20%, demonstrating that the changes in resistance were not clinically significant.
In interpreting our data one must realize that we do not have measurements of absolute lung volume. If propofol caused bronchoconstriction this could be accompanied by an increase in functional residual capacity (FRC) (or less decrease in FRC than is usually produced by induction of anaesthesia). Under these circumstances the introduction of halothane would be expected to produce bronchodilatation and a reduction in FRC to the normal (anaesthetic) baseline. As airway resistance is volume-dependent, a decrease in FRC may result in an increase in resistance, masking the bronchodilator effect of halothane. We do not believe this possible scenario can explain our data for the following reason. As part of our multi-linear regression analysis of lung function, we produced a value for endexpiratory alveolar pressure (PA,EE in equation (1)). This measurement has been validated against direct measurements of alveolar pressure in animals. 17 End-expiratory alveolar pressure is determined by the elastic recoil of the lungs and chest wall at the absolute lung volume at which end-expiration occurs and by any externally applied positive end-expiratory pressure (provided sufficient expiratory time has been allowed for the lungs to empty to their "resting" volume). Thus PA,EE is dependent on absolute lung volume and can be used as a surrogate marker of end-expiratory lung volume, provided respiratory system compliance does not change. In this study, compliance did not change with the introduction of halothane and the mean change in PA,EE was 0.039 kPa for the non-asthmatic group and 0.017 kPa for asthmatics. These data strongly suggest that a change in lung volume did not occur with the introduction of halothane and that this potential confounder is not the reason that we did not see a significant reduction in airway resistance with halothane.
Among the different techniques used to measure dynamic respiratory mechanics that have been validated for use in children during anaesthesia, multiple linear regression techniques (MLR) are the most easily implemented. 15 16 19 During ventilation, MLR uses measurements of Pao, V and V throughout the entire respiratory cycle to calculate Crs,dyn and Rrs. We achieved consistently a good fit during mechanical ventilation (r 2 9 0.98). This good coefficient of determination suggests that the application of the single-compartment model for measurements of dynamic mechanics in our study is a good approximation of the mechanical properties of the respiratory system ventilated at a single frequency.
